Related Experiment Video
Updated: Aug 12, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies
Ilan Goldenberg1, Shlomi Matetzky
1Heart Institute, Sheba Medical Center, Tel Hashomer, Israel. ilan.goldenberg@heart.rochester.edu
Insights
Contrast-induced nephropathy is a major cause of hospital-acquired acute kidney injury, linked to renal ischemia and tubular toxicity. Prevention strategies are under investigation for high-risk patients.
Area of Science:
- Nephrology and Radiology
Background:
- Contrast media use in medical imaging is increasing.
- Contrast-induced nephropathy (CIN) is the third leading cause of hospital-acquired acute renal failure.
- CIN carries significant risks of morbidity and mortality.
Purpose of the Study:
- To review the current evidence on causes, pathogenesis, and clinical course of CIN.
- To summarize therapeutic prevention strategies evaluated in clinical trials.
Main Methods:
- Review of current evidence on CIN.
- Analysis of clinical trials for prevention strategies.
Main Results:
- CIN results from renal ischemia and direct toxic effects on renal tubular cells.
- Patients with pre-existing renal insufficiency, diabetes mellitus, and congestive heart failure are at highest risk.
- Risk is also influenced by contrast medium type and dose.
Conclusions:
- No definitive preventive strategy for CIN currently exists.
- Ongoing research aims to identify effective preventive measures for CIN.
- Understanding risk factors is crucial for managing CIN.
Abstract:
With the increasing use of contrast media in diagnostic and interventional procedures, nephropathy induced by contrast media has become the third leading cause of hospital-acquired acute renal failure. It is also associated with a significant risk of morbidity and death. The current understanding of the pathogenesis indicates that contrast-medium nephropathy is caused by a combination of renal ischemia and direct toxic effects on renal tubular cells. Patients with pre-existing renal insufficiency, diabetes mellitus and congestive heart failure are at highest risk. Risk factors also include the type and amount of contrast medium administered. Therapeutic prevention strategies are being extensively investigated, but there is still no definitive answer. In this article, we review the current evidence on the causes, pathogenesis and clinical course of contrast-medium nephropathy as well as therapeutic approaches to its prevention evaluated in clinical trials.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care

